18:58:10 EST Mon 19 Nov 2018
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Shell Summary
Symbol C : *MKTSHEL
Recent Sedar Documents

Shell Summary for Sept. 13, 2018

2018-09-13 20:54 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange lost 12.18 points to 714.32 Thursday. Steve Bajic's 10th capital pool shell, Huffington Capital Corp. (HU: halted), plans to acquire Nano Graphene Inc., also known as Grapheneca, for the shell's qualifying transaction. The terms are not yet available, but the target will need to sell a $4.5-million private placement.

Nano Graphene was formed in 2016. It has a production facility in Brooklyn, where it began production in July, 2017. It makes graphene powder, graphene paste and graphene composites (for instance with titanium dioxide or silicon dioxide). The company aims to eventually produce all sorts of graphene products, from batteries to dental prostheses to inks and paints.

Nano Graphene was founded by Dr. Boris Goldstein and Sergey Alekseev. Dr. Goldstein, who holds a PhD in applied mathematics, was previously the founder, chairman and chief executive officer of Software House High Technologies, a Latvian company that offered financial and enterprise software. In the early 1990s, Dr. Goldstein moved to San Francisco, where he managed a holding company called Solby Holdings. Around the same time, he founded eForex, a website for currency trading. He also served as a director of Commercial Bank of San Francisco, which later merged with First Bank & Trust.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2018 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.